Under the banner/button " Innovatio " ... came across some details that seem relevant...imo...concerning the sensitivity of the Pd test..
Can you imagine the benefit and value to Patients , Doctors and Payers to have a test that can monitor from one test to the next any changes to medication ...definitely in the field of Precision medicine Anyway... I immediately I thought of our collaboration with J&J ...this is where we are monitoring through Pd the responsiveness of patients to Canagliflozin and how that is reflected in their risk profile for CKD ...
I'll leave you to join the dots ....from the AGM webcast ...Dr RL mentioned that the J&J collaboration results will likely be "first cab off the rank " glta
PIQ Price at posting:
74.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)